Global blockchain supervision and query platform

English
Download

China’s fintech ambitions drive interest in Venom Blockchain

China’s fintech ambitions drive interest in Venom Blockchain WikiBit 2025-09-09 22:13

Reports from Toutiao indicate that a leading Chinese fintech company is in discussions to acquire blockchain technology from the Venom Foundation. While

Blockchain

Chinas fintech ambitions drive interest in Venom Blockchain

Reports from Toutiao indicate that a leading Chinese fintech company is in discussions to acquire blockchain technology from the Venom Foundation. While details of the negotiations remain confidential, sources suggest the goal is to integrate Venoms infrastructure into financial services that support the real economy, from supply chain finance to cross-border settlements.

The talks echo a familiar pattern. Chinese companies have a track record of moving into blockchain and digital asset sectors through bold acquisitions or strategic pivots, triggering market reactions.

One notable case came from the crypto exchange Huobi, which pursued a strategy of overseas acquisitions starting in 2018, buying licenses and platforms in Japan and Singapore after Beijing tightened domestic regulation. The strategy enabled Huobi to maintain a global presence despite restrictions at home, though it also underlined how Chinese players often rely on foreign partnerships to keep pace with global innovation.

Venom employs dynamic sharding to handle high transaction volumes and bottlenecks, a fair-ordering layer to address market manipulation issues, and cross-chain interoperability with Ethereum Virtual Machine (EVM) and Web Assembly (WASM).

However, analysts note that supply chain finance would benefit the most from Venoms blockchain-based data credit system. Potential applications are wide-ranging. Supply chain finance has long been a bottleneck for small and medium-sized enterprises, where banks hesitate to extend credit due to limited data. Blockchain could help build a transparent “data credit” system to reduce that gap.

For investors, the possible Venom deal raises familiar questions. Could it mirror Huobis experience, where overseas acquisitions became the foundation for long-term strategy despite regulatory headwinds?

The negotiations are expected to extend into late 2025 or early 2026. Regardless of the outcome, the story reflects a broader structural shift: blockchain is steadily moving into the infrastructure layer of Chinas financial system.

Disclaimer:

The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

  • Crypto token price conversion
  • Exchange rate conversion
  • Calculation for foreign exchange purchasing
/
PC(S)
Current Rate
Available

0.00